This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., University of Regensburg. Active years: 2023.
Company Filing History:
1 out of 4,917 
1 out of 14 
Years Active: 2023
Title: Sebastian Scheitler: Innovator in Cancer Diagnosis and Treatment
Introduction
Sebastian Scheitler is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of melanoma. His innovative approach has led to the development of methods that enhance the understanding and management of cancerous diseases.
Latest Patents
Sebastian Scheitler holds a patent titled "Means and methods for staging, typing and treating a cancerous disease." This invention focuses on diagnosing, staging, and treating cancer by detecting somatic alterations in the DNA of disseminated cancer cells (DCCs). The methods provided in this patent allow for the determination of the stage and type of cancer based on the somatic evolution of DCCs, which is indicative of the cancer's characteristics.
Career Highlights
Throughout his career, Scheitler has worked with esteemed organizations such as the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. and the University of Regensburg. His work in these institutions has contributed to advancements in applied research and education in the field of cancer treatment.
Collaborations
Sebastian has collaborated with professionals like Melanie Werner-Klein and Christoph Klein. These partnerships have fostered a collaborative environment that enhances research and innovation in cancer diagnostics and treatment.
Conclusion
Sebastian Scheitler's contributions to cancer research through his innovative patent and collaborative efforts highlight his commitment to improving cancer diagnosis and treatment. His work continues to influence the field and offers hope for advancements in medical science.